Genetic mapping of nuclear mucidin resistance mutations inSaccharomyces cerevisiae
✍ Scribed by Július Šubik; Stanislaw Ulaszewski; André Goffeau
- Publisher
- Springer-Verlag
- Year
- 1986
- Tongue
- English
- Weight
- 463 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0172-8083
No coin nor oath required. For personal study only.
✦ Synopsis
In the yeast Saccharomyces cerevisiae, two nuclear pleiotropic drug resistance mutations pdr3-1 (former designation mucPR) and pdr3-2 (former designation DRI9/T7) have been selected as resistant to mucidin and as resistant to chloramphenicol plus cycloheximide, respectively. The pdr3 mutations were found not to affect the plasma membrane ATPase activity measured in a crude membrane fraction. Meiotic mapping using strains with standard genetic markers revealed that mutation pdr3-1 is centromere linked on the left arm of chromosome II at a distance of 5.9 +/- 3.3 cM from its centromere and 11.6 +/- 3.1 cM from the marker pet9. The centromere linked pdr3-2 mutation exhibited also genetic linkage to pet9 with a map distance of 9.8 +/- 3.2 cM. These results indicate that pdr3-1 and pdr3-2 are alleles of the same pleiotropic drug resistance locus PDR3 which is involved in the control of the plasma membrane permeability in yeast.
📜 SIMILAR VOLUMES
Axenomycin inhibits protein synthesis in vivo and in vitro in Saccharomyces cerevisiae. The antibiotic acts by binding to ribosomes, most probably to the large ribosomal subunit. Mutant strains resistant to axenomycin appear to contain ribosomes that are not inhibited by the antibiotic. The responsi
A recessive agal mutation leads to specific defect in sexual agglutinability specifically in a cells of the yeast Saccharomyces cerevisiae. The cryptopleurine resistance gene cryr~l, closely linked to the mating type locus, was used to select a/a strains which emerged from a/a strains by mitotic non